NEW YORK (GenomeWeb) – University of Maryland startup Biomecite Diagnostics has exclusively optioned the rights from UM Baltimore to develop molecular diagnostics to detect inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

The deal between Biomecite and University of Maryland Ventures covers technology developed by Florian Fricke and James White at the University of Maryland School of Medicine's Institute for Genome Sciences. The technology links distinctive genomic variants in the human gut microbiome to the two related, but unique forms of IBD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.